Cleveland Clinic
Early Pandemic SARS-CoV-2 Clade Shift in Cleveland May Have Reduced Mortality, Study Suggests
Analyzing clinical and genomic data, researchers saw a shift toward viral genotypes linked to reduced mortality in patients treated in Cleveland last spring.
The 20-year study showed the test provided an accurate assessment of the risk of long-term metastases and mortality for patients with localized prostate cancer.Â
Cleveland Clinic, IBM Partner on High-Performance Computing for Life Science, Healthcare Research
Under their 10-year partnership, IBM will install an early instance of its Quantum System One at Cleveland Clinic to promote AI-driven life sciences discovery.
PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment
Premium
The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ.
A TMB-high cutoff of 10 mutations per megabase doesn't predict immunotherapy responses universally well across cancer types, according to a paper published in JAMA Oncology.